The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement.
Level 5 - mechanism / opinion, no new human data
Historical review and narrative overview without new empirical data (Level 5 by design analogy).
PubMed 33492422 · doi:10.1007/s00125-020-05371-6
What was done
This is a narrative historical review examining the events leading to the discovery of insulin at the University of Toronto starting on May 17, 1921, by Frederick Banting, Charles Best, and John James Rickard Macleod, as well as an overview of major developments in insulin therapy over the past 100 years.
What was found
The abstract reports no quantitative experimental or clinical data. It qualitatively recounts that the Toronto experiments successfully demonstrated that a pancreatic extract could consistently reduce glucose, reverse ketosis, and halt the catabolic effects of type 1 diabetes, enabling rapid commercial production.
Why it matters
It provides a centenary historical summary of one of medicine's most impactful discoveries and contextualizes the ongoing evolution of insulin therapy for diabetes management.
Limits
As a historical narrative review, the article does not present primary patient data, systematic search methodologies, or quantitative meta-analyses. It relies on retrospective historical documentation.
Cited by
- supports Insulin was the first peptide isolated and used in medicine in 1921.